Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.794 EUR | -0.33% | +8.86% | -32.56% |
04-08 | Advicenne S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-25 | Advicenne: ODD designation in cystinuria | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.56% | 23.82M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.29% | 32.43B | |
+55.89% | 24.28B | |
-15.72% | 15.52B | |
-41.29% | 12.17B | |
-15.05% | 12.01B | |
-11.75% | 12B | |
+7.42% | 8.87B |
- Stock Market
- Equities
- ALDVI Stock
- News Advicenne
- Advicenne Wins Danish Marketing Approval for Distal Renal Tubular Acidosis Treatment Sibnayal